895 related articles for article (PubMed ID: 18065305)
1. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
[TBL] [Abstract][Full Text] [Related]
2. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP
Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
Seino KK; Long MT; Gibbs EP; Bowen RA; Beachboard SE; Humphrey PP; Dixon MA; Bourgeois MA
Clin Vaccine Immunol; 2007 Nov; 14(11):1465-71. PubMed ID: 17687109
[TBL] [Abstract][Full Text] [Related]
5. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R
Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of factors associated with development of clinical disease due to West Nile virus, Saskatchewan 2003.
Epp T; Waldner C; Townsend HG
Equine Vet J; 2007 Nov; 39(6):498-503. PubMed ID: 18065306
[TBL] [Abstract][Full Text] [Related]
7. Equine vaccine for West Nile virus.
Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
[TBL] [Abstract][Full Text] [Related]
8. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM
Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324
[TBL] [Abstract][Full Text] [Related]
9. Protection of horses from West Nile virus Lineage 2 challenge following immunization with a whole, inactivated WNV lineage 1 vaccine.
Bowen RA; Bosco-Lauth A; Syvrud K; Thomas A; Meinert TR; Ludlow DR; Cook C; Salt J; Ons E
Vaccine; 2014 Sep; 32(42):5455-9. PubMed ID: 25131745
[TBL] [Abstract][Full Text] [Related]
10. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
[TBL] [Abstract][Full Text] [Related]
11. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
[TBL] [Abstract][Full Text] [Related]
12. Effect of West Nile virus DNA-plasmid vaccination on response to live virus challenge in red-tailed hawks (Buteo jamaicensis).
Redig PT; Tully TN; Ritchie BW; Roy AF; Baudena MA; Chang GJ
Am J Vet Res; 2011 Aug; 72(8):1065-70. PubMed ID: 21801064
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of factors associated with positive IgM capture ELISA results in equids with clinical signs compatible with West Nile virus infection: 1,017 cases (2003).
Tanner JM; Traub-Dargatz JL; Hill AE; Van Campen H; Knight AP; Cunningham WE; Salman MD
J Am Vet Med Assoc; 2006 Feb; 228(3):414-21. PubMed ID: 16448369
[TBL] [Abstract][Full Text] [Related]
14. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine.
Kitai Y; Kondo T; Konishi E
J Virol Methods; 2011 Jan; 171(1):123-8. PubMed ID: 20974180
[TBL] [Abstract][Full Text] [Related]
15. West Nile Virus: is a vaccine needed?
Martina BE; Koraka P; Osterhaus AD
Curr Opin Investig Drugs; 2010 Feb; 11(2):139-46. PubMed ID: 20112163
[TBL] [Abstract][Full Text] [Related]
16. RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters.
Widman DG; Ishikawa T; Winkelmann ER; Infante E; Bourne N; Mason PW
Vaccine; 2009 Sep; 27(41):5550-3. PubMed ID: 19635608
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
Samina I; Havenga M; Koudstaal W; Khinich Y; Koldijk M; Malkinson M; Simanov M; Perl S; Gijsbers L; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2007 Nov; 25(49):8338-45. PubMed ID: 17977629
[TBL] [Abstract][Full Text] [Related]
18. Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine.
Davis EG; Zhang Y; Tuttle J; Hankins K; Wilkerson M
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):293-301. PubMed ID: 18838173
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).
Jarvi SI; Lieberman MM; Hofmeister E; Nerurkar VR; Wong T; Weeks-Levy C
Vaccine; 2008 Oct; 26(42):5338-44. PubMed ID: 18723064
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.
Chaintoutis SC; Diakakis N; Papanastassopoulou M; Banos G; Dovas CI
Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
